Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alisertib with Irinotecan and Temozolomide in Neuroblastoma
NCT01601535Phase 2Completed
- Sponsor
- New Advances in Neuroblastoma Therapy
- Start
- May 2012
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of alisertib in neuroblastoma, sponsored by New Advances in Neuroblastoma Therapy. Started May 2012; status: completed.
02
Drugs
alisertib
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT01601535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601535.